Big Data Precision Biotechnology Corp.
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
"AI-Screening" is an AI-powered biomedical interpretation system developed by Big Data Precision Biotechnology Corp. It accelerates the identification of cardiovascular disease biomarkers, assists doctors and patients in obtaining comprehensive systemic cardiovascular hotspot analysis reports, and provides big data analysis recommendation reports. The AI system can also analyze the relationship between daily diet and cardiovascular indices. This product has won the CES Taiwan Best Product Award and has completed clinical validation in medical institutions.
"BD-CARdio" is an ECG-AI interpretation system developed by Big Data Precision Biotechnology Corp. It accelerates the acquisition of auxiliary analysis reports for cardiovascular diseases, assists doctors and patients in obtaining analysis reports for conditions such as arrhythmia, and provides big data analysis recommendation reports. This product has completed clinical validation across four medical institutions and has successively won the Innovation Research Award from the Ministry of Economic Affairs and the Taipei Biotech Award.
"BD-CARdio" is an ECG-AI interpretation system developed by Big Data Precision Biotechnology Corp. It accelerates the acquisition of auxiliary analysis reports for cardiovascular diseases, assists doctors and patients in obtaining analysis reports for conditions such as arrhythmia, and provides big data analysis recommendation reports. This product has completed clinical validation across four medical institutions and has successively won the Innovation Research Award from the Ministry of Economic Affairs and the Taipei Biotech Award.
The content above was translated by Ai
Founded Year
2019
Unified Business No.
82876562
Status
Active
Number of Employees
0
Total Paid-in
Capital
146,424 (NT$)
Location of Company
Taiwan
, Miaoli County
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Precise B.D. specializes in the commercialization of technologies related to smart healthcare, medical AI, and medical products. In addition to winning the CES Taiwan Best Product award, the founding team has also won championships in the Communication Contest organized by the Ministry of Economic Affairs and the Cross-Strait Four Regions Entrepreneurship Competition, among others, with their innovative capabilities receiving widespread recognition. The core technical talents graduated from prestigious universities in the United States, Taiwan, and other regions, and have also served as R&D executives at Fortune Global 500 international companies.
The company is committed to leveraging the power of machine learning to create solutions that help clinicians better manage patients with cardiovascular diseases such as arrhythmia and myocardial infarction. We collaborate with leading cardiologists to develop and validate our cutting-edge solutions.
At PreciseB.D., we are dedicated to continuous innovation to provide solutions for clinicians worldwide. With the rise of digital health solutions, we are transforming patient pathways. We support this transformation by streamlining operational workflows, delivering clinical accuracy, and automating analysis. Artificial intelligence holds the promise of a future where healthcare professionals possess intelligent tools and patients receive the best care.
The company is committed to leveraging the power of machine learning to create solutions that help clinicians better manage patients with cardiovascular diseases such as arrhythmia and myocardial infarction. We collaborate with leading cardiologists to develop and validate our cutting-edge solutions.
At PreciseB.D., we are dedicated to continuous innovation to provide solutions for clinicians worldwide. With the rise of digital health solutions, we are transforming patient pathways. We support this transformation by streamlining operational workflows, delivering clinical accuracy, and automating analysis. Artificial intelligence holds the promise of a future where healthcare professionals possess intelligent tools and patients receive the best care.
The content above was translated by Ai
